Nayak Pratima, Montaser Alaa S, Hu Jie, Prevedello Daniel M, Kirschner Lawrence S, Ghalib Luma
Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Department of Neurologic Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
J Endocr Soc. 2018 Jul 27;2(9):1010-1019. doi: 10.1210/js.2018-00121. eCollection 2018 Sep 1.
The development of diabetes insipidus (DI) following transsphenoidal resection of pituitary adenomas has been associated with higher postsurgical morbidity and longer hospitalizations. Identifying these patients promptly and efficiently can lead to improved health care outcomes.
We evaluated our institution's incidence of DI following pituitary adenoma resection and assessed for preoperative risk factors that were associated with postoperative DI.
A retrospective review of 271 patients who underwent endoscopic endonasal resection of a pituitary adenoma between July 2010 and December 2016 by a single neurosurgical provider was completed.
All cases were from a single-center, academic institution.
Patients with a pituitary adenoma diagnosis confirmed on histology were included in the study. Those with previous surgery by a different provider were excluded.
The incidence of DI at our institution was 16.6% (45 of 271 patients), with only 4% (11 patients) having permanent DI. The presence of visual abnormalities (CI 1.29 to 4.75), suprasellar extension (CI 1.36 to 6.88), and maximal tumor diameter (1.02 to 1.08) was significantly associated with an increased incidence of postoperative DI ( < 0.05). Hyperprolactinemia, tumor functionality, and cerebrospinal fluid exposure were not associated with higher rates of postoperative DI ( > 0.05).
Pituitary adenoma patients presenting with visual abnormalities, suprasellar extension, or large tumors are at higher risk of developing DI postoperatively. These patients warrant closer postoperative monitoring as well as adequate preoperative counseling to decrease their postsurgical morbidity.
垂体腺瘤经蝶窦切除术后发生尿崩症(DI)与术后较高的发病率和较长的住院时间相关。及时有效地识别这些患者可改善医疗保健结果。
我们评估了本机构垂体腺瘤切除术后DI的发生率,并评估了与术后DI相关的术前危险因素。
对2010年7月至2016年12月期间由单一神经外科医生进行内镜下经鼻垂体腺瘤切除术的271例患者进行了回顾性研究。
所有病例均来自单一中心的学术机构。
组织学确诊为垂体腺瘤的患者纳入研究。排除由其他医生进行过先前手术的患者。
我们机构DI的发生率为16.6%(271例患者中的45例),仅有4%(11例患者)患有永久性DI。视觉异常(可信区间1.29至4.75)、鞍上扩展(可信区间1.36至6.88)和最大肿瘤直径(1.02至1.08)与术后DI发生率增加显著相关(<0.05)。高催乳素血症、肿瘤功能和脑脊液暴露与术后DI的较高发生率无关(>0.05)。
出现视觉异常、鞍上扩展或大肿瘤的垂体腺瘤患者术后发生DI的风险较高。这些患者术后需要更密切的监测以及充分的术前咨询,以降低其术后发病率。